MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 3411-3420 Newer>
The Motley Fool
September 2, 2004
Dave Marino-Nachison
MGM Stays in the Picture A very large and valuable pile of assets now stands to change hands, possibly quite soon. mark for My Articles 409 similar articles
The Motley Fool
September 2, 2004
Selena Maranjian
Dollars in Storage Iron Mountain stores documents, and it might store some value for you, too. mark for My Articles 63 similar articles
The Motley Fool
September 2, 2004
Rick Aristotle Munarriz
Specialty Retail Tales Not every specialty retailer is cut from the same mold -- some are just moldy. mark for My Articles 566 similar articles
CFO
September 1, 2004
John Goff
Who's the Boss? Spurred by a slew of portfolio-punishing accounting scandals and angered by decades of corporate indifference to their requests, shareholder activists want more say in how American companies are run. mark for My Articles 419 similar articles
InternetNews
September 1, 2004
Sean Michael Kerner
SCO Posts Q3 Loss as Legal Costs Mount While its copyright-themed lawsuits over Linux code work their way through the court system, the Unix vendor explains its financial results. mark for My Articles 616 similar articles
The Motley Fool
September 1, 2004
Nathan Slaughter
Winn-Dixie's Fortitude The grocery chain is struggling to turn itself around. Will investors keep the faith? mark for My Articles 26 similar articles
The Motley Fool
September 1, 2004
Seth Jayson
Bill Gates to Upgrade Fun The Microsoft man has a plan for Six Flags amusement parks. What it is, he's not saying yet. Investors bid the software stock up 30% this week. mark for My Articles 166 similar articles
The Motley Fool
September 1, 2004
W.D. Crotty
A Pall Falls Over Forest One of Forest Labs' Alzheimer's drugs fails in phase 3 trials. For investors willing to take the political risk, today's drug news has taken a battered stock, with a great balance sheet, to very reasonable price levels. mark for My Articles 251 similar articles
The Motley Fool
September 1, 2004
Bill Mann
Triumph of Hope Over Reason A frighteningly expensive drug of marginal efficacy begets triple-digit multiples? Bring on the miracles. Standard & Poor's reiterated its "buy" rating of ImClone. mark for My Articles 190 similar articles
The Motley Fool
September 1, 2004
Bill Mann
Fear September September historically offers the worst stock market performance by far. Stocks fluctuate. It may be meaningful on some level that they go down in September, but that doesn't mean they have to. mark for My Articles 436 similar articles
<Older 3411-3420 Newer>    Return to current articles.